Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: Requirement of estrogen receptor-α

Endocrinology

Volumn 141, Issue 9, 2000, Pages 3430-3439

  Klotz, Diane M ^a   Hewitt, Sylvia Curtis ^a   Korach, Kenneth S ^a   DiAugustine, Richard P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; 4,4' ISOPROPYLIDENEDIPHENOL; ARZOXIFENE; CELL NUCLEUS ANTIGEN; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; GENISTEIN; MESSENGER RNA; METHOXYCHLOR; RALOXIFENE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; GENE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UTERUS;

EID: 0034457890     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.9.7649     Document Type: Article

References (56)

1. Estrogens in the environment. III. Global health implications
2. Endocrine screening methods workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms
3. DDT-induced feminization of gull embryos
4. PCB's as environmental estrogens: Turtle sex determination as a biomarker of environmental contamination
5. Effects of estrogenic substances in the aquatic environment
6. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida
7. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast
8. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo
9. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland, and hypothalamic/pituitary axis in rats
10. Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol
11. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol
12. Lesions of testis and epididymis associated with prenatal diethylstilbestrol exposure
13. Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES)
14. Tamoxifen-associated uterine pathology in rodents: Relevance to women
15. The antiestrogen tamoxifen induces c-fos and jun-B, but not c-jun or jun D, protooncogenes in the rat uterus
16. Risk of endometrial cancer after tamoxifen treatment of breast cancer
17. Effects of raloxifene on bone mineral density, serum cholesterol concentration, and uterine endometrium in postmenopausal women
18. Effects of raloxifene hydrochloride on the endometrium of postmenopausal women
19. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals
20. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays
21. The rodent uterotropic assay: Critical protocol features, studies with nonyl phenols, comparison with a yeast estrogenicity assay
22. Alterations in steroidogenesis in alligators (Alligator mississippiensis) exposed naturally and experimentally to environmental contaminants
23. Vitellogenin synthesis in cultured hepatocytes; an in vitro test for the estrogenic potency of chemicals
24. Estrogenic potencies of several environmental pollutants, as determined by vitellogenin induction in a carp hepatocyte assay
25. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants
26. Steroid hormone induction of growth factor and oncogene expression in the uterus
27. Expression of insulin-like growth factor-1 (IGF-I) and its receptor in the peri-implantation mouse uterus, and cell-specific regulation of IGF-I gene expression by estradiol and progesterone
28. Estrogen induces insulin-like growth factor-1 expression in the rat uterus
29. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus
30. Insulin-like growth factor-1 (IGF-I) receptor-insulin receptor substrate complexes in the uterus
31. Insulin-like growth factor-1 is required for G2 progression in the estradiol-induced mitotic cycle
32. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
33. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene
34. Interactions of methoxychlor, methoxychlor base-soluble contaminant and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane with rat uterine estrogen receptor
35. Xenoestrogens released from lacquer coatings in food cans
36. Uterotropic activity of bisphenol A in the immature rat
37. LY353381·HCl: A novel raloxifene analog with improved SERM potency and efficacy in vivo
38. An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues
39. 3, following their expression in Escherichia coli as fusion proteins
40. Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75
41. Modulation of insulin-like growth factor-1 receptors and membrane-associated IGF binding proteins in endometrial cancer cells by estradiol
42. Estrogen regulation of the insulin-like growth factor-1 gene transcription involves an AP-1 enhancer
43. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
44. Differential ligand activation of estrogen receptors ER alpha and ER beta at AP1 sites
45. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
46. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonudeic acid in the wild-type and ERα-knockout mouse
47. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
48. Oestrogen receptor alpha and beta mRNA expression in human endometrium throughout the menstrual cycle
49. Cellular localization of estrogen receptor beta messenger ribonucleic acid in cynomolgus monkey reproductive organs
50. The effect of raloxifene on risk of breast cancer in postmenopausal women. Results from the MORE randomized trial
51. Uterine effects of a 3-year raloxifene therapy in postmenopausal women younger than age 60
52. Insulin-like growth factor-1 promotes leiomyoma cell growth in vitro
53. Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators
54. The effects of tamoxifen on endometrial insulin-like growth factor-1 expression
55. Genistein, a specific inhibitor of tyrosine-specific kinases